ROYSTON IVOR - Insider Non-Derivative Transactions at Viracta Therapeutics, Inc. (VIRX) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Aug 25, 2024, ROYSTON IVOR's relationship to Viracta Therapeutics, Inc. (VIRX) is Director, and currently has 814,522 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other VIRX insiders.
Data Source: SEC.
ROYSTON IVOR - Insider Non-Derivative Transactions of VIRX Common Stock
ROYSTON IVOR - Insider Non-Derivative Transactions at VIRX
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Aug 26, 2024 | M -- (Common Stock) | 25219 | 0 | 814522 |
| May 26, 2024 | M -- (Common Stock) | 25219 | 0 | 789303 |
| Feb 26, 2024 | M -- (Common Stock) | 25219 | 0 | 764084 |
| Nov 26, 2023 | M -- (Common Stock) | 25219 | 0 | 738865 |
| Aug 26, 2023 | M -- (Common Stock) | 25219 | 0 | 713646 |
| May 26, 2023 | M -- (Common Stock) | 25219 | 0 | 688427 |
| Feb 26, 2023 | M -- (Common Stock) | 25219 | 0 | 663208 |